�鶹Ů��

Republicans have delayed more than $1 billion in funding for the President’s Emergency Plan for AIDS Relief, better known as PEPFAR, the latest complication facing a lifesaving HIV program that has been ensnared in a broader political fight around abortion. (Diamond, 10/26)

Planned Parenthood clinics across Wisconsin now are offering two drugs, commonly known as PrEP and PEP, to those at risk of HIV exposure. ... “Planned Parenthood is focused on meeting the needs of our patients across Wisconsin, and providing essential medications to prevent HIV infection is an essential piece of providing the care our communities need,” said Amy Doczy, vice president of Patient Services at Planned Parenthood of Wisconsin. “Confidential, high-quality, affordable health care is our top priority, and we look forward to welcoming all individuals who need care regardless of their insurance or immigration status, gender and sexual identity.” (Egeren, 10/26)

Though the revolutionary HIV prevention medicine is covered by most insurers, there still are huge barriers to access in Detroit and across the United States. There's no cure for HIV, but it's preventable and treatable thanks partly to pre-exposure prophylaxis, or PrEP. (Frank, 10/26)

Federal prosecutors have accused 10 people of orchestrating a $20 million scheme to “get rich” by buying and selling black-market H.I.V. medications that in some cases had been purchased from low-income patients who risked their lives by selling it. Some of those accused in the case then used the proceeds to buy luxury cars, waterfront real estate in New York City, designer clothes, jewelry and gold, according to a statement released Friday by Damian Williams, the U.S. attorney for the Southern District of New York. (Nolan, 10/20)

The American Civil Liberties Union (ACLU) filed a lawsuit against the state of Tennessee over a law that it claims violates the rights of HIV-positive people engaged in prostitution. (Kornick, 10/25)

Researchers determined that obesity can lead to reduced exposure and response to antiretroviral drugs. (Stulpin, 10/26)

The COVID pandemic forced clinicians to come up with innovative workarounds to disruptions in care for people with HIV, but ultimately proved that there's no substitute for in-person visits for this population. The first year of the pandemic was plagued with numerous interruptions to HIV care, including healthcare providers canceling visits and patients missing visits, having difficulty accessing medical care, and overall lower confidence that they actually could manage their HIV care, according to a systematic review in AIDS and Behavior. (Walker, 10/24)